Discovery study of biomarkers of small bowel lesion in Crohn's disease

Discovery study of biomarkers of small bowel lesion in Crohn's disease by proteome analysis - ProSBoC study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044695

Enrollment

Registered

2021-06-29

Start date

2021-06-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with active Crohn's small bowel lesions

Exclusion criteria

Exclusion criteria: patients who cannot undergo double-balloon enteroscopy due to bad health condition

Design outcomes

Primary

Measure	Time frame
Improvement of each biomarker 6 months after intensified medical treatment	—

Countries

Japan

Contacts

Public ContactKeiko Uesugi

Fujita Health University School of Medicine IRB

research@fujita-hu.ac.jp0562-93-2860

Outcome results